Wellcome Sanger Institute

Wellcome Sanger Institute is a non-profit, British genomics and genetics research institute, primarily funded by the Wellcome Trust. It is located on the Wellcome Genome Campus by the village of Hinxton, outside Cambridge. It was established in 1992 and named after the pharmaceutical magnate Sir Henry Wellcome and double Nobel laureate Frederick Sanger. Its aim is to understand the role of genetics in health and disease, and to uncover the foundations of life itself. The institute played a significant role in the Human Genome Project, contributing nearly one-third of the genomic sequence of the human genome, and is now focused on understanding the genetic basis of cancer, infectious diseases, and developmental disorders.

History

The Wellcome Sanger Institute was founded in 1992 as The Sanger Centre, in a collaboration between the Wellcome Trust and the Medical Research Council. It was later renamed in honor of Frederick Sanger, a pioneer of DNA sequencing. The institute was a key player in the Human Genome Project, which was a landmark international project to map and understand all the genes of human beings.

Research

The institute's research spans multiple facets of genomics, including human genetics, pathogen genetics, mouse and zebrafish models of human disease, and computational biology. It employs a variety of technologies, such as DNA sequencing, CRISPR gene editing, and bioinformatics, to study the genetic basis of disease and to understand life's complexity.

Human Genetics

The Wellcome Sanger Institute's work in human genetics aims to uncover the genetic causes of some diseases and to understand human genetic variation. This includes large-scale studies such as the UK Biobank and the 100,000 Genomes Project, which seek to link genetic variation with disease traits and outcomes.

Pathogen Genetics

Research in pathogen genetics at the institute focuses on understanding how bacteria, viruses, and parasites cause disease, and how they evolve resistance to drugs. This work supports the development of new diagnostics, treatments, and vaccines for infectious diseases.

Model Organisms

The institute also uses model organisms, such as mice and zebrafish, to study the function of genes and to model human diseases. This research helps to reveal the biological processes involved in health and disease, and can lead to the development of new treatments.

Facilities and Resources

The Wellcome Sanger Institute is located on the Wellcome Genome Campus, which houses state-of-the-art laboratories, computational facilities, and data centers. The campus is also home to other genomics and computational biology organizations, fostering collaboration and innovation in the field.

Impact

The contributions of the Wellcome Sanger Institute to genomics have been profound, influencing both basic science and the development of new medical treatments. Its work on the Human Genome Project has laid the foundation for a deeper understanding of genetic diseases, and its ongoing research continues to push the boundaries of knowledge in genetics and genomics.

See Also

• Genomics
• Human Genome Project
• Genetic Disease
• Computational Biology
• CRISPR

External Links

• Official website

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian